非肌肉浸润性膀胱癌的腔内灌注治疗进展
摘要
膀胱肿瘤是泌尿系统最常见的恶性肿瘤之一，绝大多数来自上皮组织，其中超过90％为移行上皮肿瘤，约70％表现为非肌肉浸润性膀胱癌（NMIBC）。防止肿瘤发生、进展和侵袭转移是降低膀胱肿瘤复发率和病死率的关键。膀胱腔内灌注治疗的目的主要有：杀灭残余肿瘤，预防复发和延缓进展。本文对膀胱肿瘤灌注治疗的研究进展作一综述。
出处
《国际泌尿系统杂志》
2008年第4期440-443,共4页
International Journal of Urology and Nephrology
参考文献19
-
1Ahmedin J, Rebecca S, Elizabeth W, et al. Cancer Statistics,2007. CA Cancer J Clin,2007 ,57 :43 -66.
-
2Tongaonkar HB, Dalai AV, Kulkami JN, et al. Superficial bladder cancer. A 10 year experience. Indian Journal of Cancer, 1995,32 (3) :141 - 148.
-
3Hendricksen K, Witjes J. Alfred Current strategies for first and second line intravesical therapy for nonmuscle invasive bladder cancer. Curr Opin Urol,2007,17 ( 5 ) :352 - 357.
-
4Sylvester RJ. Intravesical chemotherapy in non - muscle - invasive bladder cancer:What schedule and duration of treatment? Eur Urol, 2007,52(4) :951 -953.
-
5Friedrich MG, Pichlmeier U, Schwaibold H, et al. Long - term intravesical adjuvant chemotherapy further reduces recurrence rate compared with short - term intravesical chemotherapy and short - term therapy with bacillus Calmette - Guerin (BCG) in patients with non - muscle - invasive bladder carcinoma. Eur Urol,2007,52 (4) :1123 - 1130.
-
6Onrust SV, Wiseman LR, Goa KL. Epirubiein: a review of its intravesical use in superficial bladder cancer. Drugs Aging, 1999,15:307 -333.
-
7Kuroda M, Niijima T, Kotake T, et al. Effect of Prophylactic Treatment with Intravesical Epirubicin on Recurrence of Superficial Bladder Cancer - The 6th Trial of the Japanese Urological Cancer Research Group (JUCRG) : A Randomized Trial of Intravesical Epirubicin at Dose of 20 mg/40 ml, 30 mg/40 ml, 40 mg/40 ml. Eur Urol, 2004,45 ( 5 ) :600 - 605.
-
8Dalbagni G,Mazumdar M ,Russo P,et al. Phase Ⅱ trial of intravesical gemcitabine in BCG - refractory transitionsl cell carcinoma of the bladder. J Urol,2004,171 (4S) :72.
-
9Dalbagni G, Russo P, Bochner B, et al. Phase Ⅱ trial of intravesical gemcitabine in bacille Calmette - Guerin - refractory transitional cell carcinoma of the bladder, J Clin Oncol,2006,24:2729 - 2734.
-
10Bartoletti R, Cai T, Gacci M, et al. Intravesical gemcitabine therapy for superficial transitional cell carcinoma : results of a phase Ⅱ prospective muhiccntcr study. Urology,2005,66 (4) : 726 - 731.
-
1蔡冰,李叶平,张奕荣.输尿管鳞癌4例诊断与治疗[J].肿瘤学杂志,2010,16(2):154-155. 被引量：2
-
2郭建军,王晓玲,张丽.AgNOR变化在移行上皮肿瘤中的诊断意义[J].河南肿瘤学杂志,1993,6(1):21-23.
-
3曾会会,郑荣生.晚期乳腺癌的维持治疗[J].临床肿瘤学杂志,2013,18(12):1145-1149. 被引量：6
-
4王卉,金朝林,江燕萍.CT灌注成像在腹腔肿瘤应用中的新进展[J].实用医学杂志,2010,26(2):174-175. 被引量：1
-
5黎明亚,莫谷良.高聚金葡素联合铂类腔内灌注治疗癌性胸/腹水的疗效观察[J].肿瘤防治杂志,2000,7(1):105-106. 被引量：2
-
6苏红,芮章荣,诸禹平.丝裂霉素加异搏定膀胱内灌注预防膀胱癌术后复发的疗效观察[J].安徽医科大学学报,1999,34(1):63-64. 被引量：1
-
7周洪月,郑继成.膀胱癌的腔内灌注治疗[J].河北医药,1995,17(5):301-302.
-
8陈丹,何肇晴.香菇多糖联合顺铂治疗恶性胸腹腔积液的疗效观察[J].中国医刊,2013,48(10):46-48. 被引量：2
-
9赵荣芳,胡建民.膀胱灌注治疗膀胱癌的临床观察及护理[J].现代医药卫生,2003,19(8):1052-1053.
-
10汪东亚,夏术阶.卡介苗腔内灌注治疗浅表性膀胱肿瘤[J].世界临床药物,2003,24(6):334-340.
